Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News AI used to predict future flares of ulcerative colitis activity Ulcerative colitis assessment could be improved after new research shows that an AI model could predict flare-ups and complications after reading biopsies.
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
03 August 2022 Successful Round of Multiple Academic Promotions for Institute 2022 Eight academics within the Institute of Immunology and Immunotherapy at the University of Birmingham have been promoted in the 2022 academic promotion round.
04 May 2022 Institute of Immunology and Immunotherapy welcomes new Professor of Regenerative Medicine Professor Ivan Wall has been appointed as Professor of Regenerative Medicine with the Institute of Immunology and Immunotherapy at the University of Birmingham.
03 May 2022 Insights shared from patient workshop on the use of artificial intelligence at capsule endoscopy Patients suffering with inflammatory bowel disease were invited to take part in a focused workshop at the University of Birmingham to assess their experiences.
07 March 2022 Opinion: Understanding the link between oral and gut health The relationship between oral health and overall health has been a focus for research for some time, explain Professors Iain Chapple and Tariq Iqbal.
16 February 2022 New study explores unique approach to treat a rare liver disease A UK research study looking into a new approach to treat primary sclerosing cholangitis, a rare disease where the body's immune attacks its own liver.
01 February 2022 Study shows impaired antibody response to COVID-19 vaccination in blood cancer and arthritis patients being treated with widely used drug Certain blood cancer and arthritis patients have a significantly reduced antibody response to double COVID-19 vaccination in the first six months of being treated with a widely used drug, reveals a new study.
31 January 2022 Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection Patients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the general population, according to a new study led by the University of Birmingham.